SLC19A1 pharmacogenomics summary.
Yee
Sook Wah
SW
Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA.
Gong
Li
L
Badagnani
Ilaria
I
Giacomini
Kathleen M
KM
Klein
Teri E
TE
Altman
Russ B
RB
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000097:blood / Q000378:metabolism; D006224:Cricetinae; D003412:Cricetulus; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects / Q000097:blood / Q000378:metabolism; D051379:Mice; D010597:Pharmacogenetics; D058978:Reduced Folate Carrier Protein / Q000235:genetics*
D000964:Antimetabolites, Antineoplastic; D058978:Reduced Folate Carrier Protein; C548699:SLC19A1 protein, human; D008727:Methotrexate
Biochem Pharmacol. 1998 Apr 1;55(7):1135-8
9605439
Gastroenterology. 1997 Mar;112(3):783-91
9041240
Somat Cell Mol Genet. 1998 May;24(3):143-56
10226652
Lung Cancer. 2005 Sep;49(3):299-309
15922487
J Clin Oncol. 2009 Dec 10;27(35):5972-8
19901119
J Clin Invest. 2005 Jan;115(1):110-7
15630450
Am J Clin Nutr. 2006 Mar;83(3):708-13
16522921
Int J Cancer. 2007 Jun 15;120(12):2696-703
17311260
Biochem Biophys Res Commun. 1995 Jan 17;206(2):681-7
7826387
J Biol Chem. 1998 Nov 13;273(46):30189-98
9804775
Blood. 1997 Feb 1;89(3):1013-8
9028333
Biochem J. 2002 Nov 1;367(Pt 3):629-40
12144527
Mol Genet Metab. 2001 Jul;73(3):285-6
11461197
J Pediatr Hematol Oncol. 2006 Feb;28(2):64-8
16462575
Clin Cancer Res. 2001 Nov;7(11):3416-22
11705857
J Biol Chem. 2002 Nov 15;277(46):43873-80
12228234
Gene. 1998 May 12;211(2):331-41
9602167
Ann Hum Genet. 2009 Sep;73(Pt 5):484-91
19650776
Ann Epidemiol. 2006 May;16(5):352-6
16019224
Cancer Metastasis Rev. 2007 Mar;26(1):111-28
17334909
Rheumatol Int. 2007 Sep;27(11):1057-61
17404734
Blood. 2006 Apr 15;107(8):3288-94
16368880
Blood. 2007 Apr 1;109(7):3050-9
17119116
J Biol Chem. 1995 Jul 21;270(29):17468-75
7615551
Leukemia. 2002 Dec;16(12):2379-87
12454742
J Biol Chem. 1997 Apr 25;272(17):11165-70
9111015
J Biol Chem. 1998 Jul 24;273(30):19065-71
9668089
Cancer Causes Control. 2010 Apr;21(4):597-608
20037791
BMC Cancer. 2008 May 01;8:124
18452618
J Biol Chem. 1999 Apr 9;274(15):10388-94
10187828
Hum Genet. 2007 Dec;122(5):525-33
17891500
Eur J Cancer. 2006 Dec;42(18):3206-11
16962770
Cancer. 2004 Feb 15;100(4):773-82
14770434
Life Sci. 2005 Oct 14;77(22):2735-42
15964598
J Clin Oncol. 2010 Feb 1;28(4):614-9
19841321
J Biol Chem. 2000 Oct 6;275(40):30855-63
10899164
Pharmacogenomics J. 2007 Dec;7(6):404-7
17325736
Am J Physiol Cell Physiol. 2002 Jun;282(6):C1512-7
11997266
J Biol Chem. 1995 Feb 17;270(7):2987-92
7852378
Clin Cancer Res. 2003 Feb;9(2):837-44
12576457
Mol Genet Metab. 2000 Aug;70(4):310-5
10993718
J Biol Chem. 1994 Jan 7;269(1):17-20
8276792
Blood. 1999 Mar 1;93(5):1643-50
10029593
Eur J Pediatr Surg. 2001 Dec;11 Suppl 1:S14-7
11813127
Blood. 2009 Mar 5;113(10):2284-9
19020309
J Rheumatol. 2008 Apr;35(4):562-71
18322994
Blood. 2010 Jun 10;115(23):4671-7
20335220
Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2528-39
19706844
Pharmacogenetics. 2004 Nov;14(11):733-9
15564880
J Biol Chem. 2008 Jul 25;283(30):20687-95
18499665
Semin Vasc Med. 2005 May;5(2):87-97
16047262
Am J Med Genet. 2002 Feb 15;108(1):1-6
11857541
Eur J Cancer. 2009 Sep;45(13):2391-401
19501504
Blood. 2007 May 15;109(10):4151-7
17264302
Gynecol Oncol. 2006 Dec;103(3):1031-7
16875718
Mol Genet Metab. 2008 Feb;93(2):95-103
17983788
Blood. 2002 Nov 15;100(10):3832-4
12411325
Biochem J. 2002 Nov 1;367(Pt 3):741-50
12139489
J Biol Chem. 1998 Oct 2;273(40):25953-60
9748272